Serina Therapeutics (SER) Non-Current Assets (2017 - 2026)
Serina Therapeutics (SER) posted Non-Current Assets of $784,000 for Q2 2026, down 17.5% from $950,000 a year earlier.
Powered by 
Analysis
Serina Therapeutics (SER) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Serina Therapeutics' Non-Current Assets came in at $871,000, down 16.9% from FY2024.
- Annual Non-Current Assets shows a five-year compound annual growth rate of -11.9% (FY2020 to FY2025).
- In prior years, Serina Therapeutics' Non-Current Assets was $1.05 million in FY2024 (-22.3%), $1.35 million in FY2023 (+71.2%), $788,000 in FY2022 (-14.3%) and $920,000 in FY2021 (-44.0%).
- The Q2 2026 figure stands as the lowest quarterly Non-Current Assets in data going back to Q4 2017.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q4 2023, with growth of 71.2%; the weakest was Q2 2024, with a decline of 83.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Serina Therapeutics | 29.17 Mn | -11.58 Mn | - | 784,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 784,000.00 |
| Dec 31, 2025 | 871,000.00 |
| Sep 30, 2025 | 916,000.00 |
| Jun 30, 2025 | 950,000.00 |
| Mar 31, 2025 | 977,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.79 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | 11.07 Mn |
| Jun 30, 2023 | 10.93 Mn |
| Mar 31, 2023 | 10.78 Mn |
| Dec 31, 2022 | 788,000.00 |
| Sep 30, 2022 | 821,000.00 |
| Jun 30, 2022 | 854,000.00 |
| Mar 31, 2022 | 887,000.00 |
| Dec 31, 2021 | 920,000.00 |
| Sep 30, 2021 | 952,000.00 |
| Jun 30, 2021 | 985,000.00 |
API Access
Serina Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();